Virax Biolabs Group Ltd. Class A VRAX 深 滬
等待開盤 01-13 09:30:00 美东时间
0.342
-0.020
-5.52%
華盛通- 最 高0.3751
- 今 開0.36
- 成交量 13.54万股
- 最 低 0.342
- 昨 收 0.362
- 總市值 148.50万
- 52周最高 2.33
- 市盈率 靜 --
- 換手率 3.12%
- 52周最低 0.31
- 委 比 80.00%
- 總股本 434.20万
- 歷史最高 290.00
- 量 比 0.30
- 振 幅 9.14%
- 歷史最低 0.31
- 每 手 1
- 風險率 0.47%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 14.1% to...
01-09 05:06
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Imunon (NASDAQ:IMNN) shares increased by 8.8% to $3.6 during Wednesday...
2025-12-25 05:05
Virax Biolabs Announces $5M Ordinary Shares Offering
Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, announced today that it has entered into
2025-12-04 02:58
快讯 | Virax Biolabs Group Limited宣布完成500万美元的私募配售。
Virax Biolabs Group Limited Announces $5 Million Private Placement
2025-12-04 02:53
Virax Biolabs Group Shares Clinical Progress, Intends To Report Clinical Data From UK PAIS Trial In 2026
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, today highlighted key milestones,
2025-12-03 20:38
Virax Biolabs Completes Patient Recruitment For UK-Based, Multi-Centre Clinical Study Evaluating Performance Of ViraxImmune Assay In Detecting T Cell Dysfunction In PAIS, Including Long COVID, PTLD, And ME/CFS
Virax Biolabs Group Limited (NASDAQ:VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases, today announced that it has
2025-11-03 21:32
EXCLUSIVE: Virax Biolabs Inks Research Pact To Advance Long COVID Diagnostic Studies
Virax Biolabs partners with Emory University to study its T cell diagnostic ViraxImmune for long COVID, aiming for FDA guidance and U.S. market entry.
2025-08-26 19:15
World Health Organization Says MPOX Remains A Public Health Emergency Of International Concern
https://www.who.int/news/item/09-06-2025-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-upsurge-of-mpox-2024-temporary-recommendations
2025-06-09 22:22
FibroBiologics announces CFO appointment
FibroBiologics (NASDAQ:FBLG) announced the appointment of Jason D. Davis, CPA, as chief financial officer, effective immediately. Davis most recently served as CFO of Virax Biolabs (VRAX). FBLG shar...
2025-06-09 20:42
